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its ability to bind protein phosphatase 1a (PP1a).16,17 This was
shown to counter the translational arrest concomitant with PKR
activation and eIF2a phosphorylation, thereby promoting viral
replication and virulence. Recent data, however, consistent with
autophagy being an eIF2a‑ and PKR‑dependent pathway, shows
that ICP34.5 antagonizes induction of xenophagy following HSV‑1
infection.13‑15 It was originally thought that ICP34.5 controlled
xenophagy solely through its ability to bind PP1a, but it was further
discovered that a 20 amino acid stretch of ICP34.5 is responsible
for its binding to Beclin 1, a protein required for autophagosome
formation.13 An HSV‑1 recombinant lacking these 20 amino acids of
ICP34.5 is severely neuroattenuated and fails to inhibit xenophagy,
demonstrating that the interaction between ICP34.5 and Beclin 1 is
required for full HSV‑1 neurovirulence.
These findings raised a number of questions. First, are the severe
replication defects in vitro and in vivo of ICP34.5‑null viruses due to
their inability to counteract autophagy, or their inability to dephos‑
phorylate eIF2a and prevent the subsequent shutoff of protein
synthesis? Second, what are the relative roles of the ICP34.5 Beclin
1‑ or PP1a‑binding domains in the control of xenophagy? Finally,
are other HSV‑1 proteins involved in the regulation of xenophagy?
To answer the first question, we utilized primary atg5‑/‑ murine
embryonic fibroblasts (MEFs) which are unable to undergo
autophagy18,19 in conjunction with an ICP34.5‑deficient virus.20
This virus has a severe replication defect in primary wild‑type MEFs
that is completely restored in pkr‑/‑ MEFs.15 We hypothesized that
the inability to control autophagy may contribute to the severe
replication defect of an ICP34.5‑null virus in wild‑type MEFs and
expected to observe partial restoration of replication in autophagy
defective MEFs. Surprisingly, the replication of this ICP34.5‑null
virus was unchanged in atg5‑/‑ MEFs suggesting that an inability to
control xenophagy does not affect virus replication in cultured cells.
In further support of these data, the Beclin 1 binding mutant and
control wild‑type viruses grew comparably in wild‑type MEFs. These
data are consistent with the idea that counteracting translational
shutoff via regulation of the PKR pathway is the primary role for
ICP34.5 in mediating efficient viral replication in vitro. This raises
yet another question. Why is the inability to control xenophagy so
important for replication in vivo, especially in the brain? The answer
may lie in inherent differences between primary cultured cells and
cells in vivo. Alternatively, xenophagy may be a more potent and
critical anti‑viral pathway in certain cell types, providing the
host with a distinct advantage of having a relatively selective and
non-destructive way to clear intracellular pathogens. This may be
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Autophagy functions in part as an important host defense
mechanism to engulf and degrade intracellular pathogens, a process
that has been termed xenophagy. Xenophagy is detrimental to the
invading microbe in terms of replication and pathogenesis and
many pathogens either dampen the autophagic response, or utilize
the pathway to enhance their life cycle. Herpes simplex virus type
1 (HSV-1) counteracts the induction of xenophagy through its
neurovirulence protein, ICP34.5. ICP34.5 binds protein phosphatase 1a to counter PKR-mediated phosphorylation of eIF2a, and
also binds the autophagy-promoting protein Beclin 1. Through
these interactions, ICP34.5 prevents translational arrest and downregulates the formation of autophagosomes. Whereas autophagy
antagonism promotes neurovirulence, it has no impact on the replication of HSV-1 in permissive cultured cells. As discussed in this
article, this work raises a number of questions as to the mechanism
of ICP34.5-mediated inhibition of autophagy, as well as to the role
of autophagy antagonism in the lifecycle of HSV-1.
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Autophagy, or perhaps more correctly a specific type of autophagy
termed xenophagy,1 is an important host defense mechanism against
a number of chronic intracellular pathogens.2‑15 Typical of many
microbial countermeasures against innate immunity, recent work has
shown that autophagy is either inhibited by the invading pathogen,
or exploited to actually enhance its replication cycle. The processes
of autophagy and xenophagy and their alteration by microbes
is, therefore, a newly‑discovered pivotal aspect of the fascinating
cat‑and‑mouse game of microbial pathogenesis and host‑pathogen
interactions.
One well‑studied example of a xenophagy‑altering factor is
the herpes simplex virus type‑1 (HSV‑1) neurovirulence protein,
ICP34.5 (Fig. 1). For some years ICP34.5 was known to counteract
the host innate immune response mediated by PKR by directing the
dephosphorylation of the translation initiation factor eIF2a through
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HSV-1 and xenophagy

degradation of otherwise hard‑to‑treat intracellular pathogens, or to
deny certain pathogens access to the autophagic machinery which
serves to promote their replication and disease.
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especially important in organs such as the brain where cells are largely
post‑mitotic, and cytokine‑ and inflammatory cell‑mediated damage
would have an irreversible, devastating outcome. In support of this
hypothesis, the Beclin 1 binding domain mutant was neuroattenu‑
ated and unable to efficiently replicate in the brains of mice. From
the teleological perspective of the pathogen, therefore, control of
autophagy may be more critical for growth in tissues with high
constitutive autophagy levels.21
To answer the second question regarding the relative roles of
Beclin 1‑ and PP1a‑binding in ICP34.5‑mediated control of
xenophagy, we generated an ICP34.5 mutant that lacks the PP1a
binding domain, but its Beclin 1‑binding domain remains intact. By
comparing the phenotypes of the ICP34.5 Beclin 1 binding mutant,
the PP1a binding mutant, and that of a null mutant we are deter‑
mining the roles of these domains in viral replication, pathogenesis,
and control of xenophagy. Finally, we think it is likely that another
HSV‑1 protein, US11, contributes to the control of xenophagy.
US11 blocks the activity and/or activation of PKR mediated by
dsRNA or PACT.22,23 Since autophagy is PKR‑dependent, US11
likely acts in concert with ICP34.5 to control autophagy through
counteracting the PKR pathway. As opposed to HSV‑1 strains which
lack ICP34.5, US11‑null viruses grow normally in vitro and are
slightly attenuated in vivo.24‑26 These small phenotypes may be due
to compensation by the dominant effect of extant ICP34.5. We have
therefore generated an HSV‑1 double mutant that is unable to bind
Beclin 1 and lacks US11and are determining whether US11 contrib‑
utes to control of xenophagy.
It is clear that our understanding of the interrelationship between
viruses and the autophagy pathway is in its infancy, but given the
broad impact of xenophagy on many viruses, and their intricate
subversive countermeasures, it seems likely that a wealth of infor‑
mation is likely to emerge in the coming years.27 It is also possible
that a better understanding of these pathways could lead to a whole
new class of antiviral therapies, designed to augment the xenophagic

io

Figure 1. Representative electron micrograph of atg5+/+ MEFs infected with
an HSV‑1 recombinant lacking ICP34.5. Higher numbers of autophagosomes and numbers of virions within autophagosomes were observed for
ICP34.5‑deleted viruses relative to wild‑type. Scale bar = 200 nm.
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